BLOG / 🇺🇸 United States / broad market · · monthly

US Pre-Market SEC Filings Roundup — October 20, 2026

USA Before-Market Intelligence

By Gunpowder Editorial ·

13 high priority 37 medium priority 50 total filings analysed

Executive Summary

The overnight US SEC filing set for 2026-10-19 to 2026-10-20 is dominated by corporate-governance and capital-markets activity rather than broad operating results. Insider sales and beneficial-ownership exits cluster in small caps and de-SPAC names, with Cable One's Graham-affiliated exit at steeply declining prices (about $13.02 to $6.07 in six sessions) the most notable negative signal.

Several large financing and M&A events stand out: Kimberly-Clark's $4.9 billion notes offering tied to the Kenvue deal, Peoples Bancorp's two pending bank acquisitions, and Northrop Grumman's raised 2026 guidance alongside slipping segment margins. Earnings-quality tension recurs: Synchrony Financial's Q3 net earnings fell 17% YoY despite record purchase volume, and Pacific Airport Group's 3Q26 revenue jumped 21.8% YoY while aeronautical revenue grew only 2.6%. Many 6-K filings (TC Energy, POET, Innate, ING, ZTO and others) are cover-only exhibit submissions whose substance could not be verified from the provided text. Watch items cluster around Kimberly-Clark's note closing (October 29), the Copley extension vote (October 29), the ATII/Forge Nano post-merger governance, and the Woori and POSCO earnings calls.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Schedule 13D · Form 4 · Schedule 13G · 425 · DEFA14A · S-3 · 8-K · DEF 14A

Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from October 19, 2026.

Investment Signals (10)

  • Cable One (CABO) (BEARISH)
    ▲

    Graham-affiliated trusts sold shares Oct 13-19 with weighted average price falling from about $13.02 to $6.07; holdings cut below 5% in a 13D/A exit with no management explanation

  • Northrop Grumman (NOC) (BULLISH)
    ▲

    Q3 sales up 7% to $11.1B, diluted EPS $7.89 vs $7.67, backlog $109.6B with book-to-bill 1.5x, and 2026 segment operating income and MTM-adjusted EPS guidance raised

  • Peoples Bancorp (PEBO) (BULLISH)
    ▲

    Q3 2026 EPS $0.91 vs $0.78 linked quarter, NIM up to 4.31% from 4.23%, provision down to $3.6M from $4.7M, but core EPS gain is smaller than the headline after $0.13 of non-core items

  • Q3 2026 net earnings $892M ($2.68/share), down 17% YoY, ROE down 410 bps to 21.0%, CET1 down to 12.9% from 14.3%, despite purchase volume up 8% to a record $49.7B

  • ▲

    Fiscal 2026 revenue $4,641.1M (+35.7% YoY), net income $473.0M (+42.3% YoY), operating margin up to 10.0% from 9.5%, though gross margin slipped to 12.0%; stock rose 59.4% after results

  • 3Q26 revenue MXN 11.67B (+21.8% YoY), 9M26 net income +11.1%, but Montego Bay aeronautical revenue fell 28.2% in 3Q and EBITDA margin dropped to 52.0% from 53.1%

  • Pricing a $4.9B five-tranche senior notes offering to fund the Kenvue cash consideration, with a 101% special mandatory redemption if the deal fails

  • Equinor (EQNR) (NEUTRAL)
    ▲

    Ongoing buy-backs with 4,167,500 shares repurchased under the employee programme and a third-tranche total of 8,238,107 shares for NOK 3.28B; recent purchases at NOK 429 vs earlier cumulative average near NOK 345

  • Shinhan Financial (SHG) (BULLISH)
    ▲

    Completed a KRW 700B treasury buy-back (6,538,515 shares, average KRW 107,058) and is cancelling the shares, returning capital to shareholders

  • Rapport Therapeutics (RAPP) (MIXED)
    ▲

    RAP-219 Phase 2 hit its YMRS primary endpoint (3.1-point placebo-adjusted, p=0.045), but discontinuations were 24.6% vs 11.8% placebo, which tempers the win

Risk Flags (10)

  • ▼

    Graham-affiliated accounts sold continuously through six sessions as price fell roughly 53%, with no stated rationale in the 13D/A

  • Kenvue/Kimberly-Clark Financing [HIGH RISK]
    ▼

    $4.9B of notes must be redeemed at 101% if the acquisition is not consummated by the outside date, and Kenvue's exchange offers carry completion risk

  • Starry Sea Acquisition (SSEAR) [HIGH RISK]
    ▼

    3,895,270 public shares remain tendered for redemption after withdrawals, a heavy redemption signal that threatens remaining trust capital ahead of the Oct 19 EGM

  • Copley Acquisition (COPL-UN) [HIGH RISK]
    ▼

    Trust of about $183.0M and redemption price of $10.61 vs $10.59 market; failure of the extension vote forces dissolution within 10 business days and the sponsor is not obligated to fund extensions

  • Artificial Intelligence Technology Solutions (AITX) [HIGH RISK]
    ▼

    Breakeven projections assume 2.7% monthly revenue growth that exceeds trailing growth, rely on salary deferrals that remain liabilities, and the company carries a going-concern qualification and stockholders' deficit

  • ▼

    Provision for credit losses up 10% to $1.3B with a $30M reserve build vs a $152M prior-year release, efficiency ratio up 330 bps to 35.9%

  • Resale registration of up to 45,385,000 shares, more than 20 times the 2,187,500 shares sold in the September offering, creates a significant dilution overhang

  • Rapport Therapeutics (RAPP) [MEDIUM RISK]
    ▼

    Treatment-related agitation 3.2% vs 1.6% placebo and withdrawal-of-consent discontinuations of 16.7% vs 4.7%, with the FDA EOP2 meeting not until Q1 2027

  • Technical assistance fees fell 81.0% in 3Q26 and 89.4% over 9M26, and a MXN 37.9B jump in goodwill/intangibles with rising bank loans points to a large leveraged transaction

  • Northrop Grumman (NOC) [MEDIUM RISK]
    ▼

    Mission Systems margin fell to 15.8% from 16.7% and Defense Systems to 10.8% from 11.4%, with a shift toward cost-type contracts

Opportunities (8)

  • Backlog of $109.6B with 1.5x book-to-bill and raised 2026 guidance give visibility, and margin pressure is partly tied to a prior-year favorable adjustment, so underlying trend may be steadier than headline suggests

  • Pending Capital Bancorp (~$728.1M all-stock) and Citizens National (~$76.6M) deals with NIM expanding to 4.31% and falling provisions could support earnings growth once integrated

  • ◆

    Record fiscal 2026 with net income +42.3% and a 59.4% share price move after results, but the stock remains a candidate for continued re-rating if operating margin expansion persists

  • Completed KRW 700B buy-back with cancellation of 1.39% of issued shares, supporting per-share metrics for holders

  • ◆

    Active repurchase programme with 540,275 shares bought in the week of 12-16 Oct at a VWAP of NOK 425.49 supports the share price as a routine return of capital

  • Statistically positive primary endpoint with progressive week-by-week separation (0.9 then 2.2 then 3.1 points) and two Phase 3 trials planned for 2H 2027, a potential value inflection if tolerability concerns are resolved

  • Caldera/Synlogic (SPAC-style combination) (OPPORTUNITY)
    ◆

    Pending NYSE American listing under 'CALD' with fixed exchange ratios and a concurrent financing, which could create a value-capture event if the structure closes as planned

  • Harel/Elbit Systems (ESLT) (OPPORTUNITY)
    ◆

    5.2% passive stake disclosed by a large Israeli insurer, indicating institutional accumulation in a defense name with pressure on defense spending (Northrop) supporting sector demand

Sector Themes (6)

  • Insider Selling in Small/Mid Caps (THEME)
    ◆

    CFOs and CPOs at Grab sold under 10b5-1 plans at about $3.00 and Ionis executives sold at $43.54, which reads as routine diversification rather than conviction signal, but cluster of sales in the same window warrants monitoring

  • SPAC and De-SPAC Redemption and Dilution Pressure (THEME)
    ◆

    Starry Sea (3.9M shares tendered), Copley (extension vote, possible dissolution), NuCube (AIDEA shares at a 14.5% discount to the $10.82 reference with half-warrants), and Healthy Choice's 20x resale overhang all show dilution and redemption dynamics

  • Bank Earnings Quality and M&A (THEME)
    ◆

    Peoples Bancorp and Synchrony show NIM and EPS gains partly offset by non-core items, reserve builds, and lower ROE, with bank consolidation (Peoples' $728M and $77M deals) continuing through all-stock structures

  • Revenue Growth vs Margin/Profit Divergence (THEME)
    ◆

    Pacific Airport (+21.8% revenue, flat operating margin), Northrop (+7% sales, lower margins) and Fabrinet (+35.7% revenue, GAAP gross margin down 10 bps) show top-line strength not translating into proportional margin expansion

  • Cover-Only 6-K Filings with Unverifiable Substance (THEME)
    ◆

    At least eight foreign private issuers (TC Energy, POET, Innate, ING, ZTO, KE Holdings, Zhihu, EMERA, GreenPower, Phaos) furnished press releases or exhibits not included in the provided text, so their content could not be assessed

  • Capital Return Activity Among Global Majors (THEME)
    ◆

    Equinor's buy-back, Shinhan's completed treasury programme and Kimberly-Clark's acquisition financing reflect large-cap capital allocation choices in a period of M&A and buy-back activity

Watch List (8)

  • $4.9B notes expected to close on or about October 29, 2026; watch Kenvue exchange-offer results and Q4 2026 deal completion timing

  • Copley Acquisition (COPL-UN)
    👁

    Extraordinary general meeting October 29, 2026 on extension to November 2, 2027; watch redemption levels against a trust of about $183.0M and any dissolution trigger

  • Starry Sea Acquisition (SSEAR)
    👁

    EGM postponed to October 19, 2026; watch final redemption count against 3,895,270 tendered shares

  • Cable One (CABO)
    👁

    Post-exit trading and any follow-on Graham-affiliated sales; watch for management explanation given the 53% price decline

  • Woori Financial Group (WF)
    👁

    Q3 2026 earnings release conference October 23, 2026 at 16:00 KST

  • POSCO Holdings (PKX)
    👁

    Provisional Q3 2026 earnings and business plan on November 2, 2026 at 3:00 pm KST

  • Host Digital/Healthy Choice (HOST)
    👁

    Resale registration of up to 45.4M shares; watch for selling-stockholder activity and share price pressure

  • Rapport Therapeutics (RAPP)
    👁

    FDA End-of-Phase 2 meeting planned for Q1 2027; watch for any update on RAP-219 discontinuation and agitation data

Filing Analyses (50)
Innventure, Inc. SC 13D/A negative materiality 7/10

19-10-2026

Ascent Capital Partners LLC, together with managers Jonathan Loeffler and Mark A. Pomeroy Jr, reports beneficial ownership of 9,310,922 Class A shares of Innventure, Inc. (INVLW), or 10.72% of outstanding Class A common stock, via Schedule 13D/A filed October 19, 2026. The filing discloses purchases of 1,738,498 shares on October 16, 2026 and 2,702,138 shares on October 19, 2026, and an aggregate acquisition cost of approximately $1,421,220. In a concurrent letter to the Board, Ascent criticized the company's sale of up to $60 million in stock at a valuation it considers significantly below intrinsic value and urged the Board to reconsider its capital strategy and engage with shareholders.

  • · Ascent describes its holdings as shares held by private funds and separately managed accounts it advises, and notes it also holds securities in private companies in which Innventure has ownership.
  • · Ascent states the position was acquired for investment purposes and that it intends to engage with management and the Board on strategy and governance.
  • · Exhibits referenced include the Ascent letter to the Board, a NAV Methodology document, and a NAV Scorecard.
Acushnet Holdings Corp. 4 neutral materiality 5/10

19-10-2026

Director Misto Holdings Corp. disposed to the issuer 583,527 Common Stock at $89.97 (~$52.5M). Misto Holdings Corp. holds 28,940,126 shares after the transaction.

  • · Director Misto Holdings Corp. disposed to the issuer 583,527 Common Stock at $89.97 (~$52.5M)
AST SpaceMobile, Inc. 4 neutral materiality 3/10

19-10-2026

Chief Accounting Officer Bernal Maya had withheld for taxes 3,935 Class A Common Stock at $40.66 (~$160K). Bernal Maya holds 128,514 shares after the transaction.

  • · Chief Accounting Officer Bernal Maya had withheld for taxes 3,935 Class A Common Stock at $40.66 (~$160K)
Grab Holdings Ltd 4 negative materiality 4/10

19-10-2026

Chief Financial Officer Oey Peter Henry sold 50,000 Class A Ordinary Shares at $2.98 (~$149K). Oey Peter Henry holds 6,753,470 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Chief Financial Officer Oey Peter Henry sold 50,000 Class A Ordinary Shares at $2.98 (~$149K)
Grab Holdings Ltd 4 negative materiality 3/10

19-10-2026

Chief Product Officer Kandal Philipp Wolfgang Josef sold 30,000 Class A Ordinary Shares at $3.00 (~$90K). Kandal Philipp Wolfgang Josef holds 3,928,735 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Chief Product Officer Kandal Philipp Wolfgang Josef sold 30,000 Class A Ordinary Shares at $3.00 (~$90K)
Cable One, Inc. SC 13D/A negative materiality 7/10

19-10-2026

Donald E. Graham filed a Schedule 13D/A reporting that, as of October 19, 2026, he beneficially owned 282,882 shares of Cable One, Inc. (CABO) common stock, or approximately 4.99% of the 5,673,925 shares outstanding as of July 31, 2026, and that he had ceased to be a more-than-5% holder, making this an exit filing. Between October 13 and October 19, 2026, Graham-affiliated trusts and accounts sold shares in a series of open-market transactions at declining weighted average prices, from about $13.02 on October 13 to about $6.07 on October 19. The sales are a negative signal for the stock, though the filing itself contains no management commentary explaining the reasons for the exit.

  • · Graham-affiliated sales spanned October 13, 15, 16, 19 and 14, 2026, with a weighted average price falling from roughly $13.02 (Oct 13) to $9.00 (Oct 14), $8.34–$8.52 (Oct 15), $7.23–$7.98 (Oct 16), and $6.07–$6.63 (Oct 19).
  • · Holdings are spread across a revocable trust, several trusts with Daniel L. Mosley as co-trustee, and Graham's direct holdings; the filing states Graham disclaims beneficial interest in certain trust shares.
  • · The filing is a Schedule 13D/A exit amendment; the reporting person states he ceased to own more than 5% of outstanding common stock on October 19, 2026.
Evernorth Holdings Inc. SC 13G neutral materiality 5/10

19-10-2026

Arrington XRP Capital Fund, LP, together with its general partner Arrington Capital Management, LLC and managing member Jack Michael Arrington, filed a Schedule 13G reporting beneficial ownership of 4,704,137 Class A shares of Evernorth Holdings Inc., representing 19.9% of Class A shares outstanding as of October 9, 2026. The filing reports that the holdings are capped at 19.9% by the issuer's RippleWorks Maximum Ownership Restriction, which blocks conversion of 29,033,708 non-voting Class C shares and issuance of 84,653 warrant shares that would otherwise lift ownership above that cap. The filing is a passive-investor disclosure, certified as not held for the purpose of influencing control.

  • · Filed under Rule 13d-1(c) as a passive investor, with a certification that the shares are not held to change or influence control of the issuer
  • · Under a letter agreement dated October 17, 2025, RippleWorks has the right to direct voting of the DAT Side Pocket Shares, and the Fund must consult RippleWorks on their disposition, so RippleWorks may be deemed to share voting and dispositive power
  • · The reporting persons disclaim group membership and disclaim beneficial ownership of RippleWorks' securities except to the extent of pecuniary interest
  • · Event date of the reportable change is listed as 10/09/2026, with the filing signed October 19, 2026
SKK Holdings Ltd SC 13G/A neutral materiality 4/10

19-10-2026

Chun Seong Ng filed a final Schedule 13G/A exit filing reporting that he sold 233,517 Class B Ordinary Shares to Rantizo, Inc. on October 9, 2026, under a Securities Purchase Agreement dated May 1, 2026. Following the sale, the reporting person beneficially owns 0 shares (0%), ending his beneficial ownership reporting obligation. The filing is an exit disclosure rather than a new strategic development.

  • · The filing is the final amendment to Schedule 13G and serves as an exit filing for the reporting person
  • · The sale was executed under a Securities Purchase Agreement dated May 1, 2026, with Rantizo, Inc. and certain other shareholders
  • · The issuer's name changed from SKK Holdings Ltd to Rantizo (name change dated August 24, 2023)
  • · Filing states the subject company's Class B shares are associated with par value $0.0025 and the issuer's CUSIP is G8292E102
SKK Holdings Ltd SC 13G/A neutral materiality 3/10

19-10-2026

Xiaoyan Liao filed the final amendment to Schedule 13G (an exit filing) reporting that she sold 782,372 Class B Ordinary Shares to Rantizo, Inc. on October 9, 2026, under a Securities Purchase Agreement dated May 1, 2026, and now beneficially owns 0 shares (0.00%). The filing is limited to beneficial ownership disclosure and contains no operating, financial, or performance results.

  • · Filing is an exit filing; the reporting person's Schedule 13G obligation terminates with this amendment
  • · Securities Purchase Agreement dated May 1, 2026 governed the share sale to Rantizo, Inc.
  • · Filing references Rule 13d-1(d) and is marked as a LIVE filing
  • · The filing lists the subject company as Rantizo (formerly SKK Holdings Ltd, name changed August 24, 2023), and the Class B share description and CUSIP G8292E102 relate to that issuer
  • · Filing lists internal inconsistencies in the cover data: the EIN and SIC code (water/sewer construction) do not appear to match a holding-company profile, and the Reporting Person's address appears as Singapore on one line and Houston, TX on another, so the registrant details should be verified against EDGAR before relying on them
IONIS PHARMACEUTICALS INC 4 negative materiality 4/10

19-10-2026

EVP, Chief Human Resources Ofc Devers Shannon L. sold 1,357 Common Stock at $43.54 (~$59.1K). Devers Shannon L. holds 17,811 shares after the transaction.

  • · EVP, Chief Human Resources Ofc Devers Shannon L. exercised/converted 2,820 Common Stock
  • · EVP, Chief Human Resources Ofc Devers Shannon L. sold 1,357 Common Stock at $43.54 (~$59.1K)
  • · EVP, Chief Human Resources Ofc Devers Shannon L. exercised/converted 2,820 Restricted Stock Unit
IONIS PHARMACEUTICALS INC 4 negative materiality 5/10

19-10-2026

EVP Research Swayze Eric sold 53 Common Stock at $43.54 (~$2.31K). Swayze Eric holds 390 shares after the transaction.

  • · EVP Research Swayze Eric exercised/converted 125 Common Stock
  • · EVP Research Swayze Eric sold 53 Common Stock at $43.54 (~$2.31K)
  • · EVP Research Swayze Eric exercised/converted 125 Restricted Stock Unit
SKK Holdings Ltd SC 13D neutral materiality 6/10

19-10-2026

Phillip Oldridge filed a Schedule 13D reporting beneficial ownership of 6,166,402 Class A ordinary shares of Rantizo (formerly SKK Holdings Ltd), representing approximately 9.02% of the 68,344,237 shares outstanding. The shares were acquired on October 9, 2026, through a pro rata distribution to Oldridge as a shareholder of Rantizo, Inc., which received the shares as consideration under an Asset Purchase Agreement and Securities Purchase Agreement dated May 1, 2026. Oldridge states he supports a proposed redomiciliation of the issuer to the United States and may seek changes to the board and management.

  • · Shares were acquired on October 9, 2026, as a pro rata distribution at closing of the asset purchase transaction, not through open-market purchase
  • · Oldridge reports no borrowed funds were used to acquire the shares
  • · Oldridge is a Canadian citizen and the filing is made from Houston, Texas
  • · Oldridge reports no transactions in the shares in the prior 60 days apart from the reported acquisition
  • · A Waiver Agreement dated October 9, 2026 is referenced as Exhibit C, filed with the issuer's Form 6-K on October 13, 2026
ATII Holdings Inc. 425 mixed materiality 7/10

19-10-2026

Archimedes Tech SPAC Partners II Co. (ATII) shareholders approved the business combination with Forge Nano, Inc. at an extraordinary general meeting held October 16, 2026, with 16,530,280 ordinary shares (55.9% of 29,590,000 outstanding) represented. All seven proposals, including the Business Combination Proposal (15,416,866 FOR vs. 1,113,414 AGAINST), the Domestication Merger, the director slate, the stock issuance, and the equity incentive plan, were approved. Pubco will be renamed Forge Nano Holdings, Inc. upon closing, and some advisory governance proposals drew more substantial opposition (for example, 2,065,390 AGAINST on the authorized share increase).

  • · Proposal 6A (Authorized Shares) received 2,065,390 AGAINST votes, the largest opposition among the advisory governance proposals
  • · Director elections for Paul Lichty and Ben Landen each drew about 1.5 million AGAINST votes, more than the roughly 1.1 million AGAINST for the other nominees
  • · Advisory proposals 6B through 6F each drew roughly 2.07 million AGAINST votes, indicating a consistent minority objection to the Proposed Charter provisions
  • · The Registration Statement on Form S-4 was declared effective by the SEC on September 22, 2026, and the Definitive Proxy Statement was filed September 24, 2026
  • · The merger agreement was originally entered into April 20, 2026 among ATII, Pubco, Merger Sub I, Merger Sub II, and Forge Nano, Inc.
  • · The filing furnishes a press release (Exhibit 99.1) announcing shareholder approval, and that furnished information is not deemed filed under Section 18 of the Exchange Act
BSR Real Estate Investment Trust 6-K neutral materiality 3/10

19-10-2026

BSR Real Estate Investment Trust filed a Form 6-K on October 19, 2026 (signed October 16, 2026) furnishing a Notice of Change of Auditor as Exhibit 99.1, along with a Former Auditor Response Letter (Exhibit 99.2) and a Successor Auditor Response Letter (Exhibit 99.3). The filing is an administrative governance disclosure with no financial results, amounts, or operating metrics disclosed in the body provided. The registrant is a Form 40-F filer, indicated by the checked box.

  • · Commission File Number 001-43491
  • · Registrant's principal executive office is at 333 Bay Street, Suite 3400, Toronto, Ontario, and the filing lists a (501) telephone number
  • · Filing is made under Rule 13a-16 / 15d-16 for the month of October 2026
  • · Financial statements, auditor names, and reasons for the auditor change are not included in the provided text and would reside in the referenced exhibits
EMERA INC 6-K neutral materiality 5/10

19-10-2026

Emera Incorporated filed a Form 6-K for October 2026 furnishing Exhibit 99.1, a Material Change Report dated October 16, 2026, which is incorporated by reference into its Form F-10 and Form F-3 registration statements. The filing body itself contains no financial figures, operational details, or description of the material change; the substance resides in the referenced exhibit, which was not included in the provided content.

  • · Filing type is Form 6-K under Rule 13a-16/15d-16 for the month of October 2026, Commission File No. 001-42631.
  • · Registrant is a Form 40-F filer (Form 20-F box unchecked), indicating MJDS eligibility.
  • · Exhibit 99.1 (Material Change Report dated October 16, 2026) is incorporated into Form F-10 (File Nos. 333-291985, 333-294020) and Form F-3 (File Nos. 333-294017, 333-294017-01, 333-294017-02), suggesting the disclosed change may be relevant to pending or active securities offerings.
  • · Principal executive offices are located at 5151 Terminal Road, Halifax, Nova Scotia, Canada.
GREENPOWER MOTOR Co INC. 6-K neutral materiality 2/10

19-10-2026

GreenPower Motor Company Inc. furnished a Form 6-K for October 2026 under Rule 13a-16, submitting as Exhibit 99.1 a press release dated October 16, 2026. The filing itself is a cover document containing no financial figures, and its substance is contained in the attached press release, which was not included in the provided content. The 6-K was signed by CFO Michael Sieffert.

  • · Commission File Number 001-39476; registrant headquartered at #240 - 209 Carrall Street, Vancouver, British Columbia V6B 2J2
  • · Registrant files annual reports on Form 20-F (not Form 40-F)
  • · Attached Exhibit 99.1 is a press release dated October 16, 2026, whose content is not reproduced in the provided text
Phaos Technology (Cayman) Holdings Ltd 6-K neutral materiality 3/10

19-10-2026

Phaos Technology Holdings (Cayman) Limited filed its annual report on Form 20-F for the fiscal year ended April 30, 2026, announced via a press release dated October 16, 2026, which is furnished as Exhibit 99.1 to this Form 6-K. The filing is a procedural disclosure that references the annual report and financial results but does not itself disclose the financial figures, which are contained in the press release and the 20-F.

  • · Fiscal year ended April 30, 2026 is the period covered by the annual report and financial results
  • · Company principal executive office is located at 55 Ayer Rajah Crescent #05-05, Singapore 139949
  • · Commission File Number 001-42952
  • · Company files annual reports on Form 20-F rather than Form 40-F
POET TECHNOLOGIES INC. 6-K neutral materiality 2/10

19-10-2026

POET Technologies Inc. furnished a Form 6-K on October 19, 2026 (signed October 16, 2026) attaching a press release dated October 16, 2026 as Exhibit 99.1. The filing itself contains no quantitative disclosures; its substance is entirely incorporated by reference to the attached press release, which was not included in the content provided.

  • · Filing is a Form 6-K for the month of October 2026 by a foreign private issuer that files annual reports on Form 20-F
  • · Commission File Number 000-55135; principal executive office at 120 Eglinton Avenue East, Suite 1107, Toronto, Ontario, Canada
  • · Exhibit 99.1 (press release dated October 16, 2026) is incorporated by reference but its contents are not included in the provided filing text, so no financial figures, product news, or strategic details can be verified from this document
  • · Recommend retrieving Exhibit 99.1 to determine the substantive subject matter before assigning materiality or Instagram suitability
TC ENERGY CORP 6-K neutral materiality 2/10

19-10-2026

TC Energy Corporation furnished a Form 6-K under the Exchange Act for October 2026, attaching as Exhibit 99.1 a copy of its news release dated October 16, 2026. The filing itself is a cover document signed by Jane M. Brindle, Vice-President, Law and Corporate Secretary, and contains no financial results, transactions, or regulatory actions. The substantive content lies in the referenced news release, which is not reproduced in the text provided.

  • · Registrant files annual reports on Form 40-F rather than Form 20-F.
  • · Commission File No. 1-31690; principal executive offices at 450 – 1 Street S.W., Calgary, Alberta, Canada.
  • · Exhibit 99.1 (news release dated October 16, 2026) is furnished, not filed, and is not incorporated by reference into Securities Act registration statements.
  • · The provided content does not include the text of the October 16, 2026 news release, so no financial or operational details can be verified from this filing.
STARRY SEA ACQUISITION CORP DEFA14A mixed materiality 6/10

19-10-2026

STARRY SEA ACQUISITION CORP (SSEAR) filed a DEFA14A soliciting-material notice (dated October 16, 2026) updating shareholders on its Extraordinary General Meeting in lieu of an annual general meeting. The meeting, originally set for October 9, 2026, was postponed to October 19, 2026 to allow more time for shareholder engagement. Redemption requests were withdrawn for 601,847 public shares, while 3,895,270 public shares remain tendered for redemption, a development that bears directly on the vote outcome and the company's remaining trust capital.

  • · Meeting originally scheduled for 10:00 a.m. ET on October 9, 2026, postponed to 9:00 a.m. ET on October 19, 2026
  • · Public shareholder redemption deadline expired at 5:00 p.m. ET on October 15, 2026
  • · Net tendered redemptions of 3,895,270 shares remain after withdrawals, indicating substantial shareholder redemption intent
  • · Company is an Emerging Growth Company incorporated in the Cayman Islands, a SPAC-style blank check vehicle with units, shares, and rights listed on Nasdaq
VAIL RESORTS INC DEFA14A mixed materiality 5/10

19-10-2026

Vail Resorts filed soliciting material under Rule 14a-12 (DEFA14A) on October 19, 2026, containing a company statement issued October 15, 2026 in response to journalist inquiries, including a Denver Business Journal article. The statement cites management's 16-month transformation effort, record guest satisfaction last year, increased lift ticket market share, and outperformance versus the industry on upcoming season pass sales, while noting the forward-looking Epic Experience growth strategy. The filing is connected to the company's solicitation of proxies for its 2026 annual meeting, and no specific financial figures were disclosed.

  • · The filing is tied to a proxy solicitation for the 2026 annual meeting, with a WHITE proxy card referenced, indicating an active shareholder proxy contest or contested governance situation
  • · The company cites outperformance versus the industry on pass sales for the upcoming season but provides no quantitative figures
  • · The 2025 annual meeting proxy statement was filed with the SEC on October 30, 2025
  • · No dollar amounts, earnings figures, or period-over-period financial metrics are disclosed in this filing
HEALTHY CHOICE WELLNESS CORP. S-3 mixed materiality 7/10

19-10-2026

Healthy Choice Wellness Corp. (renamed Host Digital Inc., NYSE American ticker changed from HCWC to HOST effective September 18, 2026) filed a Form S-3 registration statement to register for resale by Selling Stockholders up to 45,385,000 shares of Class A common stock, following its September 17, 2026 business combination with Host LLC, which became a wholly owned subsidiary. The company also raised approximately $17.5 million gross from a public offering of 2,187,500 shares at $8.00 per share, completed September 21, 2026, while its legacy natural and organic grocery retail operations continue as a division. The registration creates potential dilution and selling pressure, which the filing explicitly flags as a risk to the share price.

  • · Company is shifting from a natural grocery/wellness business to an AI and high-performance computing data center platform, with on-grid and behind-the-meter power strategies
  • · Selling Stockholders' resale of up to 45,385,000 shares is more than 20 times the 2,187,500 shares sold in the September offering, a significant dilution overhang
  • · Company will receive no proceeds from resale of registered shares; proceeds from Pre-Funded Warrant exercises would be nominal (~$1,989)
  • · Filing references a Form 10-Q/A filed August 18, 2026 and an 8-K filed September 17, 2026 as incorporated documents
  • · Company elected not to opt out of the JOBS Act extended transition period and claims emerging growth company and smaller reporting company status
Aureus Greenway Holdings Inc S-3 neutral materiality 6/10

19-10-2026

Powerus Corporation (formerly Aureus Greenway Holdings Inc., Nasdaq: PUSA) filed an S-3 registration statement covering the resale by selling stockholders of up to 7,409,209 shares of common stock. The Company receives no proceeds from these resales. The registrant completed its business combination with Autonomous Power Corporation (dba Powerus) on October 1, 2026, and now operates an autonomous systems and defense technology business alongside its legacy golf country club segment in Florida.

  • · Merger Agreement signed March 8, 2026; business combination completed October 1, 2026, with the Company renamed Powerus Corporation.
  • · Company receives no proceeds from the selling stockholders' sales; proceeds go to general corporate purposes only if the Company sells securities under the shelf.
  • · Company has never paid cash dividends and does not anticipate doing so for the foreseeable future.
  • · Risk factors flag dilution from future offerings and potential selling pressure on the stock price once the resale shares become tradable.
  • · Filing incorporates by reference the FY2025 10-K, Q1 and Q2 2026 10-Qs, and numerous 8-Ks from February through October 2026, plus S-4 audited financials for Autonomous Power Corporation, Kaizen Aerospace, and Agile Autonomy.
  • · Filing date discrepancy: the header states the registration was filed October 16, 2026, while the metadata lists October 19, 2026.
Sonic Holdco, Inc. S-4/A mixed materiality 7/10

19-10-2026

Sonic Holdco, Inc. (Parent) filed an amended S-4 registration statement/proxy statement/prospectus for a two-step reverse recapitalization under a new holding company that combines Synlogic, Inc. (a non-operating shell with discontinued product development, delisted from Nasdaq) and Caldera (an early clinical-stage biopharmaceutical company with no product revenue and significant ongoing net losses). The proposed transaction is conditioned on NYSE American listing approval, a concurrent financing, and Section 351(a) tax treatment, and carries material execution, dilution, and profitability risks.

  • · Parent expects to trade on NYSE American under the proposed symbol 'CALD' following closing; listing approval is a closing condition that may be waived by the parties without re-solicitation.
  • · The Mergers are expected to be accounted for as a reverse recapitalization, with Caldera treated as the accounting acquirer of Synlogic.
  • · Exchange ratios are fixed and will not adjust for changes in Synlogic's market price.
  • · Synlogic has identified a material weakness in internal control over financial reporting as of December 31, 2025.
  • · Parent is an emerging growth company and will rely on JOBS Act accommodations, including reduced disclosure and extended accounting transition periods.
  • · Caldera is substantially dependent on CLD-423, its only product candidate, a bispecific antibody with limited clinical and regulatory precedent.
  • · Synlogic stockholders and Caldera stockholders are entitled to appraisal rights under Section 262 of the DGCL.
  • · Synlogic's board may pursue dissolution and liquidation if the Mergers are not completed and no superior alternative exists.
Innate Pharma SA 6-K neutral materiality 2/10

20-10-2026

Innate Pharma S.A. (IPHYF) furnished a Form 6-K dated October 20, 2026, attaching a press release dated the same day as Exhibit 99.1. The filing itself is a cover-and-signature document under Rule 13a-16 and contains no financial figures, operational updates, or other substantive disclosures within the body text; the substance resides in the referenced press release, which was not included in the content provided.

  • · The filing lists Form 20-F as the annual report form, indicating Innate Pharma is a foreign private issuer filing under 20-F rather than 40-F
  • · Commission File Number 001-39084 and principal executive office located at 117 Avenue de Luminy, 13009 Marseille, France
  • · Exhibit 99.1 (Press Release dated October 20, 2026) is referenced but its content is not included in the provided filing text and should be reviewed for substantive disclosures
PEOPLES BANCORP INC 8-K mixed materiality 8/10

20-10-2026

Peoples Bancorp reported Q3 2026 net income of $32.6 million, or $0.91 per diluted share, up from $28.0 million ($0.78) in Q2 2026 but up only modestly from $29.5 million ($0.83) in Q3 2025, with non-core items reducing EPS by $0.13. Net interest margin rose to 4.31% from 4.23% linked quarter, while net losses on securities sales ($4.8 million) and acquisition-related expenses weighed on results. The company also disclosed two pending acquisitions: Citizens National Corporation (approximately $76.6 million, cash and stock) and Capital Bancorp, Inc. (approximately $728.1 million, all stock), announced September 30, 2026.

  • · Net interest income rose 3% year over year, while the provision for credit losses fell to $3.6M from $4.7M linked quarter and $7.3M a year earlier.
  • · Accretion income from acquisitions declined to $1.0M from $1.7M a year earlier, shrinking its margin contribution from eight to four basis points.
  • · Non-core items reduced Q3 2026 EPS by $0.13, versus $0.18 in Q2 2026 and $0.07 in Q3 2025, so the year-over-year EPS gain is smaller than the headline suggests on a core basis.
  • · First nine months 2026 provision for credit losses was $18.0M, down from $34.1M in the same period of 2025, and net losses on securities reached $13.9M versus $3.7M.
  • · Non-interest expense rose $4.6M year over year, driven by professional fees tied to acquisitions, salaries, and operating lease expense.
  • · Capital Bancorp consideration is all stock, which may dilute existing shareholders, while the Citizens transaction includes both cash and stock.
NuCube Energy, Inc. 425 mixed materiality 6/10

20-10-2026

NuCube Energy announced a $25 million direct investment from the Alaska Industrial Development and Export Authority (AIDEA), a state-backed investor and the anchor investor in NuCube's current financing. AIDEA agreed to purchase Class A ordinary shares at $9.25 per share, an approximately 14.5% discount to the $10.82 reference price used for the exchange ratio in NuCube's business combination with Launch Two Acquisition Corp. (NASDAQ: LPBB). The investment counts as a Transaction Financing toward the $75 million Minimum Cash Condition for closing. The filing is a Rule 425 communication tied to the pending SPAC merger, with the share sale priced below the reference price and no reported earnings or revenue results.

  • · The AIDEA investment is priced at a roughly 14.5% discount to the reference price, a material dilution-related term not reflected in the headline figure.
  • · AIDEA also receives one-half warrant per share exercisable at $11.50 within 5 years.
  • · The Business Combination Agreement dated June 25, 2026 was amended on October 19, 2026.
  • · The Form S-4 registration statement was filed September 11, 2026 and has not yet become effective; securities cannot be sold until effectiveness.
  • · The combined company is expected to list on Nasdaq upon closing, subject to listing requirements and closing conditions.
SHINHAN FINANCIAL GROUP CO LTD 6-K/A neutral materiality 3/10

20-10-2026

Shinhan Financial Group disclosed the cancellation of 6,538,515 common shares acquired under a Board of Directors resolution dated July 23, 2026, plus one additional treasury share held in respect of a fractional share, which the same Board also resolved to cancel. The estimated cancellation amount in KRW is based on the book value of the shares as of the filing date. The filing is an amendment to a prior 6-K and contains no income statement or period-over-period performance metrics.

  • · The cancellation covers both shares acquired under the July 23, 2026 Board resolution and one fractional-share treasury share, both approved for cancellation by the same Board resolution
  • · The estimated KRW cancellation amount is stated at current book value as of the disclosure filing date rather than at acquisition cost
Radiopharm Theranostics Ltd 6-K neutral materiality 3/10

20-10-2026

Radiopharm Theranostics Ltd filed a 6-K reporting Appendix 3Y-style director interest notices for changes dated 16 October 2026 across multiple insiders, all involving the cancellation of listed options (EXP 31 Jul 2029, exercise price $0.018) with no shares acquired and no cash consideration. Direct and indirect holdings are reported before and after the change, with the aggregate post-change holding showing 150,499,206 shares and 36,826,185 options. The filing is administrative in nature and does not disclose a new capital raise, acquisition, or new share issuance.

  • · Three reporting entries show cancellation of listed options dated 16 October 2026, with no shares acquired and nil consideration.
  • · Sundial Management Pty Limited, of which Mr Goodwin is a Director and Shareholder, held 2,777,778 shares and 2,777,778 options before the change and disposed of 1,111,111 listed options.
  • · The superannuation fund entry reports 9,010,253 indirect and 3,752,817 direct shares pre-change, with 1,111,111 listed options disposed.
  • · Post-change aggregate reported holdings are 150,499,206 shares and 36,826,185 options, versus 26,568,875 shares and 163,301,188 options in the direct entry pre-change.
ZTO Express (Cayman) Inc. 6-K neutral materiality 2/10

20-10-2026

ZTO Express (Cayman) Inc. furnished a Form 6-K for October 2026 that attaches Exhibit 99.1, a Next Day Disclosure Return dated October 16, 2026, and is signed by CFO Huiping Yan. The filing body contains no financial figures, operating metrics, or narrative disclosure beyond the cover page, exhibit index, and signature block, so the substantive content rests entirely in the unincluded exhibit.

  • · Filing references Exhibit 99.1, a Next Day Disclosure Return dated October 16, 2026, which is not reproduced in the provided text, so its content cannot be verified here
  • · Registrant files annual reports on Form 20-F rather than Form 40-F
  • · Principal executive offices are in Shanghai, People's Republic of China (Qingpu District)
  • · Commission File Number 001-37922
Rapport Therapeutics, Inc. 8-K mixed materiality 8/10

20-10-2026

Rapport Therapeutics reported positive topline results from its randomized, double-blind, placebo-controlled Phase 2 trial of RAP-219 in adults with acute mania associated with bipolar I disorder (253 patients). The primary endpoint was met with a 3.1-point placebo-adjusted improvement in YMRS total score at Week 3 (p=0.045), though the result is only marginally statistically significant and the trial showed a notably higher discontinuation rate on RAP-219 (24.6% vs 11.8% placebo), with withdrawal of consent as the leading reason (16.7% vs 4.7%). The Company plans an FDA End-of-Phase 2 meeting in Q1 2027 and expects to begin two Phase 3 trials in 2H 2027.

  • · Week 1 and Week 2 placebo-adjusted YMRS improvements were 0.9 and 2.2 points, showing progressive but early-stage separation from placebo
  • · Psychiatric TEAE incidence was slightly higher on RAP-219 (34.9%) than placebo (33.1%)
  • · Treatment-related agitation was 3.2% on RAP-219 vs 1.6% placebo (all-cause agitation 16.7% RAP-219 vs 9.4% placebo)
  • · Somnolence was reported less often with RAP-219 (0.8%) than placebo (3.1%)
  • · Adverse effects common to current bipolar mania medications (orthostatic hypotension, akathisia, extrapyramidal symptoms) were not reported
  • · Safety data from the eight-week post-treatment period will be presented at a future medical conference
  • · Focal onset seizure long-term open-label extension initial data expected Q4 2026; PGTCS Phase 3 expected to begin 1H 2027; LAI Phase 1 PK data expected Q3 2027; RAP-641 Phase 1 preliminary results expected 2H 2027
  • · Cash runway expected into 2H 2029, beyond expected Phase 3 FOS topline data
EQUINOR ASA 6-K neutral materiality 2/10

20-10-2026

Equinor ASA reported the buy-back of 389,058 of its shares on 15 October 2026 at a weighted average price of NOK 429.2415, for a total transaction value of NOK 166,999,840, as part of its share programmes for employees. Cumulative buy-backs under the programme now total 4,167,500 shares for NOK 1,469,846,959 at a weighted average price of NOK 352.6927. The purchases are routine employee share programme activity and do not signal a change in capital return policy.

  • · The 15 October 2026 purchase price of NOK 429.2415 was roughly 24.5% above the accumulated weighted average of NOK 344.8107 for earlier purchases under the programme.
  • · The programme's cumulative weighted average price of NOK 352.6927 is well below the price paid on 15 October, indicating recent purchases were made at higher prices than earlier ones.
EQUINOR ASA 6-K neutral materiality 3/10

20-10-2026

Equinor ASA disclosed transactions under the third tranche of its 2026 share buy-back programme for the period 12-16 October 2026, with purchases executed on the Oslo Stock Exchange (OSE) on four of the five trading days (no OSE volume reported for 15 October). Over the period, 540,275 shares were repurchased at a volume-weighted average price of NOK 425.4849, for a total of NOK 229,878,871.46. Cumulative buy-backs under the tranche now stand at 8,238,107 shares for NOK 3,282,254,732.19 at an average price of NOK 398.4234.

  • · Trading venues: Oslo Stock Exchange (OSE:EQNR), NYSE (EQNR), CEUX (EQNRO) and TQEX (EQNRO); all executed volume was reported on OSE
  • · No buy-back transactions were reported for 15 October 2026
  • · Daily weighted average share price rose from NOK 418.3224 (12 October) to NOK 431.5615 (16 October), with the period high on 16 October
  • · Equinor reported execution data on a per-day basis across the five-day window, with daily volumes ranging between approximately 132,000 and 137,775 shares on active days
ING GROEP NV 6-K neutral materiality 2/10

20-10-2026

ING Groep N.V. filed a Form 6-K on October 20, 2026, furnishing a press release dated the same day as Exhibit 99.1, which is incorporated by reference. The filing body contains no financial figures, named initiatives, or substantive disclosures; the substance resides entirely in the unattached exhibit.

WOORI FINANCIAL GROUP INC. 6-K neutral materiality 3/10

20-10-2026

Woori Financial Group Inc. filed a Form 6-K announcing that it will hold its 2026 Third Quarter Earnings Release Conference on Friday, October 23, 2026 at 16:00 Korea Time, with a live audio webcast and conference call, Q&A session, and materials posted on its website. The filing contains no financial results, so no period-over-period performance metrics are disclosed.

  • · Conference date and time: Friday, October 23, 2026 at 16:00 Korea Time
  • · Format: live audio webcast and conference call, with pre-registration available at pin.teletogether.com/eng
  • · Languages: Korean and English, with simultaneous interpretation for English-speaking participants
  • · Schedule is subject to change based on company circumstances
KIMBERLY CLARK CORP 8-K neutral materiality 8/10

20-10-2026

Kimberly-Clark priced a private offering of $4.9 billion in senior unsecured notes across five tranches maturing 2028 to 2036, with closing expected on or about October 29, 2026. Proceeds, together with cash on hand and/or commercial paper borrowings, are earmarked to fund the cash consideration for the pending acquisition of Kenvue Inc., expected to close in Q4 2026. If the acquisition is not consummated by the outside date (five business days after the later of May 31, 2027 or any agreed extension), or if Kimberly-Clark abandons the deal, the notes must be redeemed at 101% of principal plus accrued interest.

  • · Offering is not conditioned on consummation of the Kenvue acquisition, but notes carry a special mandatory redemption feature at 101% if the deal fails
  • · Notes would be fully and unconditionally guaranteed by Kenvue if the acquisition closes and Kenvue exchange offers are not completed within four business days after their expiration
  • · Exchange Offers and Consent Solicitations for Kenvue's existing senior notes commenced September 28, 2026; completion is not guaranteed on the described terms
  • · Notes are unregistered and offered only to QIBs under Rule 144A and non-U.S. persons under Regulation S
KE Holdings Inc. 6-K neutral materiality 3/10

20-10-2026

KE Holdings Inc. (BEKE) furnished a Form 6-K for October 2026 attaching five Next Day Disclosure Returns dated October 12 through October 16, 2026. The cover page and exhibit index do not disclose the substantive content of those returns, so no financial figures, operational metrics, or deal terms can be verified from this filing alone. The filing is administrative in nature and carries no quantifiable performance data.

  • · Five Next Day Disclosure Returns (Exhibits 99.1-99.5) are attached, dated October 12, 13, 14, 15 and 16, 2026, respectively.
  • · The filing is signed by CFO XU Tao on October 20, 2026.
  • · The registrant is a Foreign Private Issuer filing under Form 20-F rather than Form 40-F.
Synchrony Financial 8-K neutral materiality 4/10

20-10-2026

Synchrony Financial furnished its monthly charge-off and delinquency statistics for the thirteen months ended September 30, 2026 under Regulation FD (Item 7.01, Exhibit 99.1). The filing itself contains no specific numeric results; the figures reside in the exhibit, which was not included in the provided content. The company also stated it will continue monthly disclosure, with the last month of each quarter furnished alongside quarterly earnings.

  • · Statistics cover the thirteen months ended September 30, 2026, and are furnished as Exhibit 99.1
  • · Monthly cadence continues; the final month of each calendar quarter is released with quarterly earnings
  • · Filing is furnished, not filed, and is not subject to Section 18 liability or incorporated by reference into other filings
Artificial Intelligence Technology Solutions Inc. 8-K mixed materiality 7/10

20-10-2026

Artificial Intelligence Technology Solutions (AITX) furnished a press release projecting monthly operating cash breakeven beginning January 2027 and all-in cash breakeven (including debt service and device build expenditures) during Q2 2027. The projections assume approximately 2.7% monthly revenue growth, which the filing states exceeds the company's growth over the preceding twelve months, and expanded cash spend reductions of roughly $345,000 per month in January 2027 rising above $350,000 per month from February 2027, measured against the August 2026 expense run rate. The filing repeatedly cautions that the company has never been profitable, has a stockholders' deficit, carries a going-concern qualification, and depends on dilutive external financing, and that salary deferrals remain obligations rather than permanent savings.

  • · Filing states the assumed 2.7% monthly revenue growth exceeds the company's growth over the preceding twelve months, and that recent sequential growth does not establish the rate will continue.
  • · Projected cash savings include changes in payment timing, not only permanent expense reductions; salary deferrals and deferred compensation remain payable obligations.
  • · Revenue recognized in a month does not equal cash collected, so financing may be needed even when projected revenue exceeds included expenditures.
  • · Company states it does not qualify for the PSLRA safe harbor for forward-looking statements.
  • · Auditor's report contains a going-concern substantial doubt paragraph; the company has never been profitable in any fiscal year and reports a stockholders' deficit and negative working capital.
  • · Management measures (operating and all-in cash breakeven) are non-GAAP and do not imply GAAP profitability or elimination of accumulated liabilities.
Fabrinet DEFA14A neutral materiality 3/10

20-10-2026

Fabrinet filed a DEFA14A (definitive additional proxy soliciting material) on October 20, 2026, supplementing its proxy materials for an upcoming shareholder meeting. The filing is a cover-page-only submission with the 'No fee required' box checked and no substantive proposals, financial figures, or voting details included in the excerpt provided.

  • · Filed by the Registrant (Fabrinet), with the Definitive Additional Materials box checked rather than a preliminary or definitive proxy statement
  • · No filing fee required for this submission
  • · The excerpt contains only the cover page; the substantive supplemental content (proposals, meeting date, agenda items) is not included in the provided text
Fabrinet DEF 14A mixed materiality 5/10

20-10-2026

Fabrinet has filed its definitive 2026 proxy statement for its virtual Annual General Meeting on December 10, 2026, seeking shareholder votes on two Class II director nominees, ratification of PricewaterhouseCoopers ABAS Ltd. as auditor for fiscal 2027, and a non-binding advisory vote on named executive officer compensation. The filing reports fiscal 2026 revenue of $4,641.1 million, up 35.7% YoY, and net income of $473.0 million, up 42.3% YoY, but GAAP gross margin edged down 10 basis points to 12.0% and non-GAAP gross margin fell 20 basis points to 12.2%.

  • · Fiscal 2026 marked the sixth successive fiscal year of record revenue, net income, and net income per diluted share
  • · Closing share price rose 59.4% from $285.23 to $454.55 following fiscal year-end results announcement
  • · Operating margin improved to 10.0% from 9.5% and non-GAAP operating margin improved to 10.8% from 10.5%, despite lower gross margins
  • · Annual Report on Form 10-K for fiscal year ended June 26, 2026 was filed with the SEC on August 18, 2026
  • · Annual Meeting is virtual-only, with a fallback reconvening at 11:00 a.m. PST if technical issues affect quorum
  • · Board attendance: incumbent directors attended 100% of Board and Committee meetings in fiscal 2026
  • · Filing is classified as 'No fee required' for SEC filing purposes
POSCO HOLDINGS INC. 6-K neutral materiality 4/10

20-10-2026

POSCO Holdings Inc. filed a Form 6-K announcing that it will release provisional earnings for the third quarter of 2026 and its business plan on November 2, 2026 at 3:00 pm KST via conference call with analysts, institutional investors, and press, followed by a Q&A session. The filing contains no quantitative financial results, so no performance comparisons are available from this document.

  • · Conference call scheduled for November 2, 2026 at 3:00 pm KST at POSCO Center, Seoul (venue listed as conference call)
  • · Filing is a Form 6-K under Rule 13a-16 for the month of October 2026, filed by a foreign private issuer that files Form 20-F
Zhihu Inc. 6-K neutral materiality 2/10

20-10-2026

Zhihu Inc. furnished a Form 6-K for October 2026 attaching five Next Day Disclosure Returns dated October 12 through October 16, 2026. The filing itself contains only the cover page, exhibit index, and signature block; no financial results, deal terms, or operational figures are included in the body text provided.

  • · Filing is made under Rule 13a-16 / 15d-16 of the Securities Exchange Act of 1934 as a foreign private issuer; registrant files annual reports on Form 20-F
  • · Commission File Number 001-40253; principal executive offices in Beijing, PRC
  • · Exhibit 99.1 to 99.5 are Next Day Disclosure Returns dated October 12, 13, 14, 15 and 16, 2026, which are typically Hong Kong Exchanges and Clearing filings; the substantive content of these exhibits is not reproduced in the provided text
SHINHAN FINANCIAL GROUP CO LTD 6-K neutral materiality 4/10

20-10-2026

Shinhan Financial Group announced completion of its treasury share repurchase program, which commenced July 23, 2026, with the final acquisition settled October 20, 2026. The company acquired 6,538,515 common shares at an average price of KRW 107,058, for a total acquisition amount of KRW 699,999,932,500, representing 1.39% of total issued common shares. The filing is a routine completion disclosure with no reported change in performance metrics.

  • · Acquisition period ran from July 31, 2026 to October 16, 2026, with the final transaction settling October 20, 2026
  • · One additional fractional share from a prior share exchange is held but excluded from the treasury share count under Article 165-3 of the Financial Investment Services and Capital Markets Act
ELBIT SYSTEMS LTD SC 13G neutral materiality 4/10

20-10-2026

Harel Insurance Investments & Financial Services Ltd. filed a Schedule 13G reporting beneficial ownership of 2,424,529 Ordinary Shares of Elbit Systems Ltd (ESLT), representing 5.2% of the 46,848,460 shares outstanding as of June 17, 2026. The position is reported as passive (Rule 13d-1(c)), with the filer certifying the shares are not held to influence control of the issuer. Most of the reported shares (2,351,970) are held for public-fund and policyholder accounts managed by subsidiaries operating under independent management.

  • · Filing is a LIVE Schedule 13G under Rule 13d-1(c), a passive-investor certification rather than an activist or control filing
  • · Harel reports zero sole voting power and 2,424,529 shared dispositive power, with Item 4 noting independent management of underlying subsidiaries
  • · Event date is 10/14/2026, with the filing made 10/20/2026
Synchrony Financial 8-K mixed materiality 8/10

20-10-2026

Synchrony Financial reported Q3 2026 net earnings of $892 million ($2.68 per diluted share), down 17% from $1.1 billion ($2.86 per diluted share) in Q3 2025. Purchase volume rose 8% to a record third-quarter $49.7 billion and loan receivables grew 3% to $103.3 billion, but profitability weakened as the provision for credit losses rose 10% to $1.3 billion, other expense rose 10% to $1.4 billion, return on equity fell 410 basis points to 21.0%, and the CET1 ratio declined to 12.9% from 14.3%.

  • · Net interest margin fell 12 basis points to 15.50%
  • · Efficiency ratio rose 330 basis points to 35.9%, driven by higher operational losses, technology investment and marketing
  • · Provision rise was driven by a $30M reserve build versus a $152M release in the prior year, partly offset by $62M lower net charge-offs
  • · Other income fell 17% to $105M on higher loyalty costs
  • · Home & Auto and Diversified & Value purchase volume grew 9% and 13%, but Lifestyle period-end loan receivables fell 1%
  • · Deposits rose 4% (+$3.1B) to $83.0B and made up 83% of funding
  • · Allowance for credit losses was 10.01% of period-end loans, down from 10.09% in Q2 2026 and 10.35% in Q3 2025
  • · Management expects continued Q4 seasonality in delinquencies; Q3 net charge-offs were at a seasonal low
Sea Ltd 6-K neutral materiality 1/10

20-10-2026

Sea Limited filed a Form 6-K on October 20, 2026, attaching an internal email from Chairman and CEO Forrest Li to all employees marking the ninth anniversary of the company's initial public offering. The filing itself contains no financial results, guidance, or transaction details; it is a procedural submission of a non-financial internal communication to the SEC.

  • · The 6-K attaches Exhibit 99.1, an employee email from the CEO dated October 20, 2026, referencing the ninth anniversary of Sea's IPO.
  • · The filing includes standard forward-looking statement disclaimers and identifies Form 20-F as the annual report type (Form 40-F not checked).
  • · No material financial, operational, or regulatory information is disclosed in the filing body.
NORTHROP GRUMMAN CORP /DE/ 8-K mixed materiality 8/10

20-10-2026

Northrop Grumman reported third quarter 2026 sales up 7 percent to $11.1 billion, with net earnings of $1.1 billion and diluted EPS of $7.89 versus $7.67 a year earlier. Backlog rose to $109.6 billion on $16.4 billion of net awards (book-to-bill of 1.5x), and the company raised its 2026 guidance for segment operating income and MTM-adjusted EPS. Performance was mixed: operating margin fell to 11.4 percent from 11.9 percent, segment operating margin fell to 12.1 percent from 12.3 percent, Defense Systems and Mission Systems operating income declined, and Mission Systems and Defense Systems margins compressed year over year.

  • · Mission Systems operating margin rate fell to 15.8% from 16.7%, partly due to a prior-year $68M favorable EAC adjustment in restricted advanced microelectronics
  • · Defense Systems operating margin rate fell to 10.8% from 11.4%, driven by a shift toward more cost-type contract content; Defense Systems organic sales were not affected by training services
  • · Defense Systems and Space Systems lower armament/ammunition volume and Commercial Resupply Service sales (-$136M) were partial offsets
  • · Effective tax rate declined to 13.4% from 16.9%, supported by higher research credits
  • · Nine-month operating income rose 4% but unallocated corporate expense increased sharply to $250M from $17M, and nine-month Defense Systems operating income fell 11%
  • · Nine-month Space Systems operating income declined 9% and Aeronautics Systems nine-month operating income rose 136%
  • · Q3 operating cash flow benefited from improved trade working capital and a one-time $371M equipment sale proceeds to a customer, which flatter adjusted free cash flow
  • · Guidance raised: segment operating income midpoint up $65M, MTM-adjusted EPS midpoint up $0.70; Aeronautics Systems margin guidance updated to high 9% from mid-to-high 9%
Pacific Airport Group 6-K mixed materiality 8/10

20-10-2026

Pacific Airport Group (GPAEF) reported 3Q26 consolidated total revenues of MXN 11,667,818 thousand, up 21.8% YoY, and 9M26 revenues of MXN 34,327,155 thousand, up 8.9%. Net income rose 8.1% in 3Q26 and 11.1% for 9M26, while the operating margin was flat at 43.3% in 3Q and EBITDA margin declined to 52.0% from 53.1%. Growth was driven by Cross Border Xpress (CBX) contributions and cargo, but aeronautical revenue grew only 2.6% in the quarter, and several airports (Los Cabos, Puerto Vallarta, Montego Bay, Guanajuato, Hermosillo) reported declining EBITDA or revenues. The balance sheet shows a sharp increase in goodwill/intangibles (MXN 37,926,450 thousand) and cash, alongside a large rise in bank loans and a MXN 12,512,864 thousand dividend payable, indicating a major transaction.

  • · Montego Bay aeronautical revenues fell 28.2% in 3Q26 and 32.9% for 9M26, the steepest decline in the portfolio.
  • · Technical assistance fees dropped 81.0% in 3Q26 (to MXN 43,001 thousand) and 89.4% for 9M26.
  • · Concession taxes declined 13.8% in 3Q26, supporting margins despite higher revenues.
  • · Consolidated Balance sheet shows goodwill/intangibles of MXN 37,926,450 thousand and premium on share subscription of MXN 35,766,611 thousand, consistent with a major equity/acquisition transaction.
  • · Dividends payable of MXN 12,512,864 thousand were recorded at 9/30/2026, and current bank loans rose 286.5% YoY to MXN 19,434,447 thousand, indicating significant leverage increase.
  • · Foreign currency translation reserve swung to a deficit of MXN (231,014) thousand from a MXN 95,577 thousand reserve.
Copley Acquisition Corp DEF 14A mixed materiality 7/10

20-10-2026

Copley Acquisition Corp (COPL-UN) has filed a definitive proxy statement for an extraordinary general meeting on October 29, 2026, seeking shareholder approval to extend its business combination deadline from November 2, 2026 up to 12 one-month extensions to November 2, 2027, funded by $150,000 per monthly extension deposited into the trust account as a non-interest bearing promissory note. The Trust account holds approximately $183.0 million, with a redemption price of about $10.61 per public share versus a NYSE closing price of $10.59, and the Board cautions that completion of a business combination within the extended period is not assured.

  • · Extension Amendment requires a special resolution (two-thirds of votes cast by present/represented shares), and the Trust Agreement Amendment requires two-thirds of outstanding shares represented and voted.
  • · Shareholders may redeem Public Shares regardless of how they vote; if the proposals fail, the company must redeem all Public Shares within 10 business days and dissolve.
  • · Sponsor is not obligated to fund extensions, and warrants would expire worthless upon liquidation.
  • · The Company may still choose not to exercise an extension and liquidate on the Termination Date even if the proposals are approved.
  • · The existing charter allowed two three-month extensions (up to 24 months total), which the Extension Amendment would replace.

Get daily alerts with 10 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Pre-Market SEC Filings Roundup

🇺🇸 More from United States

View all →